💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Recordati (RECI)

Milan
Currency in EUR
Disclaimer
51.40
+0.10(+0.19%)
Closed
RECI Scorecard
Full Analysis
Has raised its dividend for 11 consecutive years
Fair Value
Day's Range
51.1551.90
52 wk Range
43.0453.40
Prev. Close
51.4
Open
51.15
Day's Range
51.15-51.9
52 wk Range
43.04-53.4
Volume
188,893
Average Volume (3m)
225,956
1-Year Change
12.74%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
RECI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
53.49
Upside
+4.07%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Recordati Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing’s syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Employees
4369
Market
Italy

Compare RECI to Peers and Sector

Metrics to compare
RECI
Peers
Sector
Relationship
P/E Ratio
27.2x13.4x−0.6x
PEG Ratio
−71.070.200.00
Price/Book
5.8x2.5x2.6x
Price / LTM Sales
4.7x2.3x3.1x
Upside (Analyst Target)
3.5%13.8%58.3%
Fair Value Upside
Unlock8.3%8.8%Unlock

People Also Watch

2.392
WBD
-0.83%
7.370
MTCM
-0.94%
6.690
BPSI
-2.48%
24.520
ERG
+0.49%
9.260
BFF
-1.70%

FAQ

What Is the Recordati (RECI) Stock Price Today?

The Recordati stock price today is 51.40

What Stock Exchange Does Recordati Trade On?

Recordati is listed and trades on the Milan stock exchange.

What Is the Stock Symbol for Recordati?

The stock symbol for Recordati is "RECI."

Does Recordati Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 2.33%.

What Is the Recordati Market Cap?

As of today, Recordati market cap is 10.53B.

What is Recordati Earnings Per Share?

The Recordati EPS is 1.88.

What Is the Next Recordati Earnings Date?

Recordati will release its next earnings report on 07 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.